Wall Street analyst Caroline Levy joins Prenetics (PRE) board
Rhea-AI Filing Summary
Prenetics Global Limited announced the appointment of Caroline Levy as an independent director to its Board, effective August 17, 2026. She will serve on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, replacing Dr. Darshan Shah on those committees while he remains an independent director on the Board.
The company also highlighted its flagship brand IM8, described as the fastest-growing premium supplement brand, with over $200 million in annualized run-rate revenue achieved within 18 months of launch, shipping to 43 countries and delivering about 200,000 servings daily. Prenetics plans to report second quarter 2026 results on August 18, 2026, via a live webcast.
Positive
- None.
Negative
- None.
Filing Explained
The 6-K also incorporates this report and its exhibits into specified F-3 and S-8 registration statements, making the materials part of those filings without disclosing that securities were offered or sold.
Key Figures
Director experience: 30+ years
IM8 annualized run-rate revenue: $200 million
Countries served by IM8: 43 countries
+3 more
6 metrics
Director experience
30+ years
Caroline Levy’s tenure as a top-ranked Wall Street consumer equity research analyst
IM8 annualized run-rate revenue
$200 million
Annualized run-rate revenue surpassed within 18 months of IM8’s launch
Countries served by IM8
43 countries
Geographic reach of IM8’s product shipments
Daily servings
200,000 servings
Approximate number of IM8 servings delivered daily
Time since IM8 launch
18 months
Period over which IM8 reached $200 million annualized run-rate revenue
Earnings webcast time
8:30 a.m. Eastern time
Scheduled time for the Q2 2026 earnings webcast on August 18, 2026
Key Terms
independent director, Audit Committee, Nominating and Corporate Governance Committee, annualized run-rate revenue, +1 more
5 terms
independent director regulatory
"appointment of Caroline Levy to its Board of Directors as an independent director"
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
Audit Committee regulatory
"Caroline will also serve on the Audit Committee, Compensation Committee"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Nominating and Corporate Governance Committee regulatory
"and Nominating and Corporate Governance Committee, replacing Dr. Darshan Shah"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
annualized run-rate revenue financial
"surpassing $200 million in annualized run-rate revenue within 18 months of launch"
Annualized run-rate revenue is an estimate of how much money a company would make over a full year based on its most recent short-term revenue, by multiplying that recent pace to cover twelve months. Investors use it like a snapshot or speedometer—helpful for spotting growing or shrinking sales quickly, but it can be misleading if recent results were unusually high or low, so it should be checked against long-term trends and seasonal effects.
NSF Certified for Sport technical
"Daily Ultimate Essentials, a 90-ingredient daily nutrition system that is NSF Certified for Sport"
NSF Certified for Sport is a third-party safety seal showing a supplement or sports product has been independently tested to be free of banned substances, contaminants and undeclared ingredients, and that it was made under quality controls. For investors, this label matters because it lowers the chance of regulatory action, athlete bans, or recalls and typically boosts consumer trust and sales—think of it as a safety inspection sticker that helps a product sell more reliably in a sensitive market.
FAQ
What board change did Prenetics Global Limited (PRE) announce on this Form 6-K?
Prenetics Global Limited announced that Caroline Levy has been appointed as an independent director to its Board, effective August 17, 2026. She also joins the Audit, Compensation, and Nominating and Corporate Governance Committees, replacing Dr. Darshan Shah on those committees while he remains on the Board.
Which board committees will Caroline Levy serve on at Prenetics Global Limited (PRE)?
Caroline Levy will serve on Prenetics’ Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. She replaces Dr. Darshan Shah on each of these committees, while Dr. Shah continues to serve as an independent director on the Board.
When will Prenetics Global Limited (PRE) report its Q2 2026 financial results?
Prenetics will report its second quarter 2026 financial results on Tuesday, August 18, 2026. Management will host a live earnings webcast at 8:30 a.m. Eastern time on StockTwits, including Q&A with research analysts and participation from the new independent director.
What scale has Prenetics’ IM8 brand reached according to this PRE Form 6-K?
IM8 has surpassed $200 million in annualized run-rate revenue within 18 months of launch. The brand ships to 43 countries and delivers approximately 200,000 servings daily, positioning it as a rapidly scaling premium supplement business within Prenetics’ consumer health portfolio.
What relevant experience does Caroline Levy bring to the Prenetics (PRE) board?
Caroline Levy brings over 30 years as a top-ranked Wall Street consumer equity research analyst. Her background includes leading U.S. consumer research at UBS, senior roles at CLSA and Macquarie, and serving on the board of Celsius Holdings, Inc. since 2020.
How is this Prenetics (PRE) Form 6-K used with the company’s registration statements?
This report, together with Exhibits 99.1, 99.2 and 99.3, is incorporated by reference into Prenetics’ Form F-3 and Form S-8 registration statements. From the submission date, it becomes part of those filings, except where later documents supersede the information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
